Metraipolis › archive › dc_9e2aa166d796
The ErbB-tyrosine kinase inhibitor, neratinib, has anti-inflammatory effects in multimorbidity by increasing macrophage efferocytosis via the upregulation of… — Europe PMC PMID:41857730
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41857730
- DOI
- 10.1186/s12950-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T05:14:20.890Z
- SHA-256 of the archived text
6bbff431889b753ecf0e50d406cb0f0c0b67864656785079ab9f79d6ba7172c4- Stable URL of this page
https://metraipolis.com/documento/dc_9e2aa166d796
How to cite
The ErbB-tyrosine kinase inhibitor, neratinib, has anti-inflammatory effects in multimorbidity by increasing macrophage efferocytosis via the upregulation of… — Europe PMC PMID:41857730 — Europe PMC (en), https://europepmc.org/article/MED/41857730 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9e2aa166d796 (Metraipolis archive dc_9e2aa166d796, sha256 6bbff431889b753ecf0e50d406cb0f0c0b67864656785079ab9f79d6ba7172c4)
BibTeX
@misc{dc9e2aa166d796,
title = {The ErbB-tyrosine kinase inhibitor, neratinib, has anti-inflammatory effects in multimorbidity by increasing macrophage efferocytosis via the upregulation of… — Europe PMC PMID:41857730},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41857730},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9e2aa166d796; sha256 6bbff431889b753ecf0e50d406cb0f0c0b67864656785079ab9f79d6ba7172c4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41857730. Agents can read the archived copy with the MCP tool read_document.